Jasper Therapeutics (JSPR) Institutional Ownership → Exposed: 10 CENT Crypto to Explode May 20th? (From True Market Insiders) (Ad) Free JSPR Stock Alerts $21.60 +0.68 (+3.25%) (As of 05/15/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Jasper Therapeutics (NASDAQ:JSPR)CurrentInstitutional OwnershipPercentage79.85%Number ofInstitutional Buyers(last 12 months)18TotalInstitutional Inflows(last 12 months)$378.64MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$551.42M Get JSPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Jasper Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data JSPR Institutional Buying and Selling by Quarter Ad Manward PressThe most important AI company you've never heard ofBecause this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.Get the full story on this secret AI company poised for massive growth Jasper Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2024Qiming U.S. Ventures Management LLC928,964$27.27M30.4%-89.1%6.168% 5/14/2024StemPoint Capital LP129,211$3.79M1.0%N/A0.858% 5/10/2024 Vanguard Group Inc.612,745$17.99M0.0%-85.0%4.069% 5/8/2024 Russell Investments Group Ltd.79,811$2.34M0.0%N/A0.530% 5/7/2024 Concurrent Investment Advisors LLC20,409$599K0.0%N/A0.136% 5/3/2024 Carlyle Group Inc.1,066,189$31.30M2.0%-87.8%7.080% Get the Latest News and Ratings for JSPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/18/2024Kingdon Capital Management L.L.C.3,540,000$2.79M0.3%+16.4%31.720% 2/15/2024Opaleye Management Inc.3,985,340$3.14M0.8%N/A35.717% 2/7/2024 Ieq Capital LLC54,500$43K0.0%N/A0.488% 2/7/2024 Monaco Asset Management SAM249,563$197K0.1%N/A2.236% 2/5/2024 Fernwood Investment Management LLC494,706$390K0.1%+8.8%4.433% 11/13/2023Mariner LLC652,749$457K0.0%-8.7%0.589% 11/9/2023 Cowen AND Company LLC200,393$140K0.0%N/A0.181% 11/8/2023Forefront Analytics LLC110,792$78K0.0%+59.7%0.100% 10/30/2023 Summit Trail Advisors LLC65,000$46K0.0%N/A0.059% 8/15/2023Sphera Funds Management LTD.4,274,008$5.86M0.9%+5.7%3.874% 8/14/2023Jefferies Financial Group Inc.489,884$671K0.0%N/A0.444% 6/1/2023Prelude Capital Management LLC54,500$99K0.0%N/A0.049% 5/16/2023Ally Bridge Group NY LLC2,517,232$4.56M6.0%N/A2.301% 5/16/2023BVF Inc. IL9,900,000$17.92M0.7%N/A9.051% 5/15/2023Affinity Asset Advisors LLC476,948$863K0.3%N/A0.436% 5/15/2023Kingdon Capital Management L.L.C.3,040,000$5.50M1.0%+463.0%2.779% 5/15/2023RTW Investments LP2,329,809$4.22M0.1%N/A2.130% 5/12/2023Forefront Analytics LLC30,290$55K0.0%-73.4%0.028% 5/5/2023 Carlyle Group Inc.8,761,891$15.77M0.5%N/A8.011% 5/3/2023 Jump Financial LLC33,074$60K0.0%N/A0.030% 4/25/2023Qiming U.S. Ventures Management LLC8,519,648$15.42M18.7%+45.6%7.789% 2/13/2023Forefront Analytics LLC114,000$55K0.0%-4.8%0.300% 2/7/2023 Fernwood Investment Management LLC454,706$220K0.1%+53.1%1.197% 11/14/2022Forefront Analytics LLC119,800$94K0.1%+246.0%0.327% 11/9/2022 Fernwood Investment Management LLC297,080$234K0.1%N/A0.810% 5/10/2022Sectoral Asset Management Inc.675,000$2.40M0.4%N/A1.782% 5/9/2022Forefront Analytics LLC32,550$118K0.0%N/A0.086% 4/27/2022Vahanian & Associates Financial Planning Inc.10,000$36K0.1%-60.0%0.026% 2/15/2022Kingdon Capital Management L.L.C.540,000$4.24M0.5%N/A1.427% 2/2/2022Grace Capital218,110$1.71M1.0%N/A0.576% 1/28/2022Vahanian & Associates Financial Planning Inc.25,000$196K0.2%N/A0.066% 11/16/2021Citadel Advisors LLC3,005,035$29.22M0.0%N/A8.228% 11/15/2021Tudor Investment Corp Et Al20,000$205K0.0%N/A0.055% 11/15/2021Abingworth LLP5,628,558$58.03M13.2%N/A15.412% Wall Street legend who predicted 2021 tech crash issues new warning (Ad)People around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch his stock warning right here, 100% free of charge(Data available from 1/1/2016 forward) JSPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of JSPR shares? During the previous two years, 23 institutional investors and hedge funds held shares of Jasper Therapeutics. The most heavily invested institutionals were Carlyle Group Inc. ($31.30M), Qiming U.S. Ventures Management LLC ($27.27M), Vanguard Group Inc. ($17.99M), BVF Inc. IL ($17.92M), Sphera Funds Management LTD. ($5.86M), Ally Bridge Group NY LLC ($4.56M), and RTW Investments LP ($4.22M).Learn more on JSPR's institutional investors. What percentage of Jasper Therapeutics stock is owned by institutional investors? 79.85% of Jasper Therapeutics stock is owned by institutional investors. Learn more on JSPR's institutional investor holdings. Which institutional investors have been buying Jasper Therapeutics stock? Of the 21 institutional investors that purchased Jasper Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($9.90M), Carlyle Group Inc. ($8.76M), Opaleye Management Inc. ($3.99M), Kingdon Capital Management L.L.C. ($3M), Qiming U.S. Ventures Management LLC ($2.67M), Ally Bridge Group NY LLC ($2.52M), and RTW Investments LP ($2.33M). How much institutional buying is happening at Jasper Therapeutics? Institutional investors have bought a total of 35,865,537 shares in the last 24 months. This purchase volume represents approximately $589.87M in transactions. Which Jasper Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Jasper Therapeutics stock in the last 24 months: Carlyle Group Inc. ($7.70M), Qiming U.S. Ventures Management LLC ($7.59M), Vanguard Group Inc. ($3.48M), Forefront Analytics LLC ($89.51K), and Mariner LLC ($62.25K). How much institutional selling is happening at Jasper Therapeutics? Institutional investors have sold a total of 18,918,356 shares in the last 24 months. This volume of shares sold represents approximately $552.97M in transactions. Related Companies: DocGo Major Shareholders Anavex Life Sciences Major Shareholders Caribou Biosciences Major Shareholders MeiraGTx Major Shareholders SOPHiA GENETICS Major Shareholders Tenaya Therapeutics Major Shareholders Candel Therapeutics Major Shareholders Black Diamond Therapeutics Major Shareholders Invivyd Major Shareholders Adaptimmune Therapeutics Major Shareholders This page (NASDAQ:JSPR) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jasper Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
